Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Experts urge early detection & better access to care
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The European regulator will conduct a re-inspection of the facility to verify the compliance
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
